Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Forskningsoutput: TidskriftsbidragLetter

Bibtex

@article{fe53e520ce5447e08b3a6f886fd6a919,
title = "Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma",
author = "Eskelund, {Christian Winther} and Alexandra Albertsson-Lindblad and Arne Kolstad and Anna Laurell and Riikka R{\"a}ty and Pedersen, {Lone Bredo} and Geisler, {Christian Hartmann} and Mats Jerkeman and Kirsten Gr{\o}nb{\ae}k",
year = "2018",
doi = "10.3324/haematol.2018.194399",
language = "English",
volume = "103",
pages = "e541--e543",
journal = "Haematologica-The Hematology Journal",
issn = "1592-8721",
publisher = "Ferrata Storti Foundation",
number = "11",

}